2. Rostami A, Riahi SM, Holland CV, et al. 2019; Seroprevalence estimates for toxocariasis in people worldwide: A systematic review and meta-analysis. PLoS Negl Trop Dis. 13:e0007809. DOI:
10.1371/journal.pntd.0007809. PMID:
31856156. PMCID:
PMC6922318.
3. Elefant GR, Shimizu SH, Sanchez MC, Jacob CM, Ferreira AW. 2006; A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J Clin Lab Anal. 20:164–172. DOI:
10.1002/jcla.20126. PMID:
16874812. PMCID:
PMC6807646.
4. Anh NT, Thuy DT, Hoan DH, Hop NT, Dung DT. 2016; Levels of Toxocara infections in dogs and cats from urban Vietnam together with associated risk factors for transmission. J Helminthol. 90:508–510. DOI:
10.1017/S0022149X15000619. PMID:
26223509.
5. Phuc LDV, Loi CB, Quang HH, et al. 2021; Clinical and laboratory findings among patients with toxocariasis in medic medical center, Ho Chi Minh City, Vietnam in 2017-2019. Iran J Parasitol. 16:538–547.
6. Ha KH, Song JE, Kim BS, Lee CH. 2016; Clinical characteristics and progression of liver abscess caused by toxocara. World J Hepatol. 8:757–761. DOI:
10.4254/wjh.v8.i18.757. PMID:
27366302. PMCID:
PMC4921797.
7. Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. 2010; Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 104:3–23. DOI:
10.1179/136485910X12607012373957. PMID:
20149289.
8. Hotez PJ, Wilkins PP. 2009; Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis. 3:e400. DOI:
10.1371/journal.pntd.0000400. PMID:
19333373. PMCID:
PMC2658740.
9. Nguyen T, Cheong FW, Liew JW, Lau YL. 2016; Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012. Parasit Vectors. 9:486. DOI:
10.1186/s13071-016-1780-2. PMID:
27595647. PMCID:
PMC5011968.
11. Chang S, Lim JH, Choi D, et al. 2006; Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol. 187:W622–W629. DOI:
10.2214/AJR.05.1416. PMID:
17114516.
12. Rayes AA, Teixeira D, Serufo JC, Nobre V, Antunes CM, Lambertucci JR. 2001; Human toxocariasis and pyogenic liver abscess: a possible association. Am J Gastroenterol. 96:563–566. DOI:
10.1111/j.1572-0241.2001.03471.x. PMID:
11232707.
13. Hombu A, Yoshida A, Kikuchi T, Nagayasu E, Kuroki M, Maruyama H. 2019; Treatment of larva migrans syndrome with long-term administration of albendazole. J Microbiol Immunol Infect. 52:100–105. DOI:
10.1016/j.jmii.2017.07.002. PMID:
28754237.
15. Ramachandran J, Chandramohan A, Gangadharan SK, Unnikrishnan LS, Priyambada L, Simon A. 2013; Visceral larva migrans presenting as multiple liver abscesses. Trop Doct. 43:154–157. DOI:
10.1177/0049475513507254. PMID:
24100348.
16. Coşkun F, Akıncı E. 2013; Hepatic toxocariasis: a rare cause of right upper abdominal pain in the emergency department. Turkiye Parazitol Derg. 37:151–153. DOI:
10.5152/tpd.2013.33. PMID:
23955916.
17. Jang EY, Choi MS, Gwak GY, et al. 2015; Enhanced resolution of eosinophilic liver abscess associated with toxocariasis by albendazole treatment. Korean J Gastroenterol. 65:222–228. DOI:
10.4166/kjg.2015.65.4.222. PMID:
25896156.
19. Biała M, Nieleńczuk J, Chodorowska A, Szetela B. 2024; Challenges in toxocariasis diagnosis: From pericarditis, through hepatic tumor, to the detection of brain aneurysms: Case report. Pathogens. 13:254. DOI:
10.3390/pathogens13030254. PMID:
38535597. PMCID:
PMC10975517.